DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Ocular Inflammation - Pipeline Insights, 2017" drug pipelines to their offering.
Ocular Inflammation - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Ocular Inflammation. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Ocular Inflammation.
The report also assesses the Ocular Inflammation therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope
The report provides competitive pipeline landscape of Ocular Inflammation
The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
Coverage of the Ocular Inflammation pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
The report reviews key players involved in the therapeutics development for Ocular Inflammation and also provide company profiling
The report also gives the information of dormant and discontinued pipeline projects
Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Overview
- Pipeline Therapeutics
- Therapeutics under Development by Companies
- Filed and Phase III Products
- Phase II Products
- Phase I and IND Filed Products
- Discovery and Pre-Clinical Stage Products
- Drug Candidate Profiles
- Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Discontinued Products
- Dormant Products
- Companies Involved in Therapeutics Development
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/nsvhld/ocular
